Compared to Semaglutide and Tirzepatide, retatrutide's special inclusion of glucagon receptor agonism along with GIP and GLP-1 receptor agonism presents a distinct pharmacological profile. Though Semaglutide is a GLP-one receptor agonist and Tirzepatide combines GLP-one and GIP receptor agonism, retatrutide's triple system could most likely deliver broader metabolic Added benefits. https://corepepptides.com/product/retatrutide-injection-pen/